drug launch

New Era; New Launch Excellence Blueprint for 2021-2022

5 min read

New Era; New Launch Excellence Blueprint for 2021-2022

5 min

John Constantine, Senior VP at Orchestrall, Inc: How to Accelerate Drug and Device Launch in the Post-COVID World

5 min read

Episode 2: How to Accelerate Drug and Device Launch in the Post-COVID World

5 min

New Era; New Launch Excellence Blueprint for 2021-2022

5 min

How Life Sciences Companies Can Level Up Healthcare Education in Post-COVID Era

5 min read

The Ultimate Guide to Omnichannel Education

5 min read

Four Fundamentals for Telling Your Clinical Evidence Story

5 min read

ACTO Named One of the 2019 PM360 ELITE 100

5 min

Channel Partners: Gaining Visibility and Creating Accountability

5 min read

CEO Parth Khanna’s Interview with Dr. Bertalan Mesko from The Medical Futurist, on Life Sciences Education

5 min read

ACTO Kicks Off 2021 with Chart-Topping Growth

5 min

ACTO Closes $11.5M Series A Round to Accelerate Virtual Transformation for Life Sciences Companies

5 min

What Does ACTO’s Acquisition of CoHealth Mean for Patient Education?

5 min read

ACTO Acquires Scrimmage

5 min read

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

5 min

ACTO Acquires Scrimmage, Disrupting Life Sciences Learning and Engagement Market

5 min

ACTO Emerges as a Leader in Life Sciences Commercialization; Closes Strong Calendar Year 2018 with 184% Revenue Growth and Doubled Customer Base

5 min

When the Rubber Meets the Road, Don’t Slip

5 min read

Channel Partners: Accessibility is the Magic Word

5 min read

Episode 3: The New Model for Crisis Leadership in Life Sciences

5 min

The Triple A Initiative: ACTO, Axiom, and AstraZeneca

5 min

The Triple A Initiative: ACTO, Axiom, and AstraZeneca

5 min